Has Simsek, D. Et Al. 2021. Complementary Role of Ga-68-Prostate-Specific Membrane Antigen and F-18-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma. CLINICAL NUCLEAR MEDICINE , vol.46, no.7 , 579-581.

Has Simsek, D., Civan, C., Erdem, S., & Sanli, Y., (2021). Complementary Role of Ga-68-Prostate-Specific Membrane Antigen and F-18-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma. CLINICAL NUCLEAR MEDICINE , vol.46, no.7, 579-581.

Has Simsek, Duygu Et Al. "Complementary Role of Ga-68-Prostate-Specific Membrane Antigen and F-18-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma," CLINICAL NUCLEAR MEDICINE , vol.46, no.7, 579-581, 2021

Has Simsek, Duygu H. Et Al. "Complementary Role of Ga-68-Prostate-Specific Membrane Antigen and F-18-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma." CLINICAL NUCLEAR MEDICINE , vol.46, no.7, pp.579-581, 2021

Has Simsek, D. Et Al. (2021) . "Complementary Role of Ga-68-Prostate-Specific Membrane Antigen and F-18-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma." CLINICAL NUCLEAR MEDICINE , vol.46, no.7, pp.579-581.

@article{article, author={Duygu HAS ŞİMŞEK Et Al. }, title={Complementary Role of Ga-68-Prostate-Specific Membrane Antigen and F-18-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma}, journal={CLINICAL NUCLEAR MEDICINE}, year=2021, pages={579-581} }